The Big Winner From the Aurora Cannabis-Organigram Deal: Curaleaf
Organigram is valuing Aurora Cannabis more highly than Curleaf, but that doesn't mean it's the best option for shareholders in the long run.
We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.